DS-1205b, a novel selective inhibitor of AXL kinase, blocks resistance to EGFR-tyrosine kinase inhibitors in a non-small cell lung cancer xenograft model

Takeshi Jimbo, Kôsaku Fujiwara|Oncotarget|2019

Cited by 47